Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)

Autor: Bang, Yung-Jue, Golan, Talia, Dahan, Laetitia, Fu, Siqing, Moreno, Victor, Park, Keunchil, Geva, Ravit, De Braud, Filippo, Wainberg, Zev A., Reck, Martin, Goff, Laura, Laing, Naomi, Mi, Gu, Oliveira, Joana M., Wasserstrom, Heather, Lin, Chia-Chi
Zdroj: In European Journal of Cancer September 2020 137:272-284
Databáze: ScienceDirect
Externí odkaz: